Physician Wealth Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Physician Wealth Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$537	Sell	1 -1	-50%	-$512	﹤0.01%	2089
2026 Q1	$1.05K	Sell	2 -1	-33%	-$478	﹤0.01%	1661
2025 Q4	$1.75K	Buy	3 +2	+200%	+$1.02K	﹤0.01%	1351
2025 Q3	$459	Buy	+1	New	+$373	﹤0.01%	1845
2025 Q2	–	Sell	-2	Closed	-$663	–	1906
2025 Q1	$663	Buy	+2	New	+$657	﹤0.01%	1300

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Physician Wealth Advisors's MDGL Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Madrigal Pharmaceuticals (MDGL) stake by 50% in Q2 2026, selling an estimated $512 and leaving 1 share worth $537. The position accounts for ﹤0.01% of the portfolio, ranked #2089.

Physician Wealth Advisors first reported a position in MDGL in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.75K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Physician Wealth Advisors held 1 share of Madrigal Pharmaceuticals worth $537 as of Q2 2026.
Physician Wealth Advisors sold 1 Madrigal Pharmaceuticals share in Q2 2026, an estimated $512.
Madrigal Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2089 holding.
Physician Wealth Advisors first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
Physician Wealth Advisors's Madrigal Pharmaceuticals position peaked at $1.75K in Q4 2025.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.